CFDA Revised the Final Version of IECIC 2014 and Consulted Public Comments
original article from CIRS
16 Jun 2015, CFDA issued a notice regarding the revision of IECIC 2014 launched on 30 Jun 2014 and consulted public comments. The public could send any comments to hzpbwh@nifdc.org.cn before 25th Jun 2015.
Background
IECIC 2014 was finalized on 30 Jun 2014 after two times’ consultation in public.
Item |
Issue date |
Number of cosmetic ingredients |
24 Jan 2014 |
8641 |
|
30 May 2014 |
8203 |
|
30 Jun 2014 |
8783 |
The revised contents cover:
- Adding 9 new ingredients into the inventory;
- Changing the product name of 111 plant ingredients;
- Cancelling 20 repeated plant ingredients and 1 plant ingredient;
- Indicating the source of 6 plant ingredients
The English version of revised contents in details issued by CFDA can be accessed here.
CIRS’ Comments
- It is possible to supplement the new ingredients to the IECIC list based on they have been used in previous approved cosmetics;
- The standard Chinese name of plant ingredients is referred from INCI inventory (2010), Flora of China, Chinese Pharmacopoeia, Tibetan Medicine Standard and Mongolian Medicine Standard ;
- PAPAVER SOMNIFERUM SEED EXTRACT will be not allowed to be used in cosmetics in China;
- There will be 8771 cosmetic ingredients allowed to be used in China when the revised contents are effective.
Source:
http://www.sda.gov.cn/WS01/CL0781/121764.html
Contact Us
- CIRS China
Hangzhou CIRS Co. Ltd (CIRS China)
11F Building 1, Dongguan Hi-Tech Park, 288 Qiuyi Road, Binjiang District, Hangzhou 310052, China
Tel: +86-571 8720 6574 | Fax: +86-571 8720 6533
Email: service@cirs-reach.com